Brainstem maturation after antenatal steroids exposure in premature infants as evaluated by auditory brainstem-evoked response

Journal of Perinatology

Volumn 23, Issue 4, 2003, Pages 307-311

  Amin, Sanjiv B ^a,c   Orlando, Mark S ^b   Dalzell, Larry E ^b   Merle, Kathleen S ^b   Guillet, Ronnie ^a  

^a Golisano Childrens Hospital at Strong   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; ILLICIT DRUG; MAGNESIUM SULFATE; STEROID;

APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BRAIN DEVELOPMENT; BRAIN MATURATION; BRAIN STEM; CHORIOAMNIONITIS; CHROMOSOME DISORDER; CONTROLLED STUDY; DATA ANALYSIS; DELIVERY; DRUG USE; EVOKED AUDITORY RESPONSE; FETUS LUNG MATURATION; GESTATIONAL AGE; HUMAN; INFANT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; NEUROTOXICITY; PREMATURITY; PRENATAL DRUG EXPOSURE; RACE; STATISTICAL SIGNIFICANCE; WAVEFORM;

BETAMETHASONE; BRAIN STEM; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; FETAL ORGAN MATURITY; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MALE; PREGNANCY; PRENATAL CARE; REACTION TIME;

EID: 0038480645     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210898     Document Type: Article

References (24)

1. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8.
2. Weichsel Jr. ME. The therapeutic use of glucocorticoid hormones in the perinatal period; potential neurological hazards. Ann Neurol 1977;2:364-6.
3. Slotkin TA, Zhang J, McCook EC, Seidler FJ. Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids. Brain Res Dev Brain Res 1998;111(1):11-24.
4. Schwab M, Antonow-Schlorke I, Kuhn B, et al. Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep. J Physiol 2001;530 (Part 3):497-506.
5. Antonow-Schlorke I, Kuhn B, Muller T, et al. Antenatal betamethasone treatment reduces synaptophysin immunoreactivity in presynaptic terminals in the fetal sheep brain. Neurosci Lett 2001;297(3):147-50.
6. Rotmensch S, Celentano C, Liberati M, et al. The effect of antenatal steroid administration on the fetal response to vibroacoustic stimulation. Acta Obstet Gynecol Scand 1999;78(10):847-51.
7. Amin SB, Merle KS, Orlando MS, Dalzell LE, Guillet R. Brain stem maturation in premature infants as a function fo enteral feeding type. Pediatrics 2000;106(2)318-22.
8. Tyson JE, Lasky R, Flood D, et al. Randomized trial of taurine supplementation for infants >1300 gram birth weight: effect of auditory brain-stem evoked responses. Pediatrics 1989;83:406-15.
9. Kohelet D, Arbel E, Goldberg M, Arlazzoroff A. Transient neonatal hypothyroxinemia and the auditory brian stem evoked response. Pediatr Res 1992;32:530-31.
10. Moller AR, Jannetta PJ, Moller MB. Neural generators of brainstem evoked potentials: results from human intracranial recordings. Ann Otol Rhinol Laryngol 1981;90:591-6.
11. Starr A. Auditory brainstem potentials: comments on their use during infant development. J Clin Neurophysiol 1984;1:331-4.
12. Hecox K, Burkard R. Developmental dependencies of the human brain-stem auditory evoked response. Ann NY Acad Sci 1982;388:538-56.
13. Amin SB, Orlando MS, Dalzell LE, Merle KS, Guillet R. Morphological changes in serial auditory brain stem responses in 24 to 32 weeks' GA infants during the first week of life. Ear Hear 1999;20(5):410-8.
14. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systemic review of RCTs. BMC Pediatr 2001;1:1.
15. Halliday HL, Ehrenjranz RA. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). Cochrane Database Syst Rev 2001;1:CD001146.
16. Esplin M, Fausett M, Smith S, et al. Multiple courses if antenatal steroids are associated with a delay in long-term psychomotor development in children with birth weights <1500 grams. Am J Obstet Gynecol. 2000;182:524.
17. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-21.
18. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus Dev Brain Res. 1990;53:157-67.
19. Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 2000;83(2):F154-7.
20. Dobbing J. The later development of the brain and its vulnerability. In: Davis JA, Dobbing J, editors. Scientific Foundations of Paediatrics. London: Heinemann; 1974. p. 565-77.
21. Liapi C, Chrousos GP. glucocorticoids. In: Jaffe SJ, Aranda JV, editors. Pediatric Pharmacology, 2nd ed. Philadelphia: WB Saunders; 1992, p. 466-75.
22. Henderson-Smart D, Pettigrew AG, Campbell DJ. Clinical apnea and brainstem neural function in preterm infants. N Eng J Med 1983;308:353-7.
23. National Institutes of Health. Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement 2000;17(2):1-10.
24. Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6.